Oncogenes like c-Myc, mTOR, and hypoxia-inducible factor 1α (HIF-1α) are able to increase glycolytic activity to meet anabolic requirements to maintain highly proliferating cancer cells [12–14]. This evidence concerns the gene MYC and cancer.